Brain Cancer Clinical Trials in Cleveland

Showing 181-200 of 226 trials

A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas

NCT00045708

Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. This phase I/II trial is studying the side effects and best dose of ixabepilone and how well it works in treating patients with recurrent glioma.

Adult Anaplastic AstrocytomaAdult Giant Cell GlioblastomaAdult Gliosarcoma+1 more

National Cancer Institute (NCI)57 participantsStarted Oct 2002

Atlanta, Georgia, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00540722

This phase II trial is studying how well gossypol works in treating patients with progressive or recurrent glioblastoma multiforme. Gossypol may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

National Cancer Institute (NCI)56 participantsStarted Jan 2008

Birmingham, Alabama, United States • Tampa, Florida, United States • Baltimore, Maryland, United States +5 more locations

TERMINATEDPhase 2< 1 mile

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

NCT01122901

This phase II trial is studying how well gamma-secretase/Notch signalling pathway inhibitor RO4929097 works in treating patients with recurrent or progressive glioblastoma. Gamma-secretase/Notch signalling pathway inhibitor RO4929097 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

National Cancer Institute (NCI)47 participantsStarted Dec 2010

Atlanta, Georgia, United States • Detroit, Michigan, United States • Cleveland, Ohio, United States +2 more locations

A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Brain Cancer Trials in Other Cities

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Pazopanib in Treating Patients With Recurrent Glioblastoma

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme

AMG 595 First-in-Human in Recurrent Gliomas

A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

MK-2206 for Recurrent Malignant Glioma

A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme

Other Conditions in Cleveland